HCWB News and Press, HCW Biologics Inc. From 05/09/23

2023-05-09 08:57:22 ET HCW Biologics press release ( NASDAQ: HCWB ): Q1 GAAP EPS of -$0.14 beats by $0.02 . Revenue of $0.01M (-99.4% Y/Y). As disclosed above, the Company entered into a development line of credit agreement for the buildout of the Company’s ...

MIRAMAR, Fla., May 09, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the lin...

2023-04-27 08:31:32 ET Clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the link between inflammation and age-related diseases, HCW Biologics ( NASDAQ: HCWB ) has a entered into a $26.2...

Provides funding for buildout of new headquarters and manufacturing facility Capital requirements now funded into 2025 MIRAMAR, Fla., April 27, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a cl...

Presentation of data for the mechanism underlying HCW9218 against solid tumors HCW9218 is the clinical-stage, lead product candidate of HCW Biologics Inc. MIRAMAR, Fla., April 13, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Bio...

2023-04-03 08:55:13 ET Summary In December of 2022 I introduced a number of stocks which I was adding to my "Tax Loss Selling Basket". In this article I summarize the logic and criteria for the basket. I then tally up the results including calculating overall returns and looki...

HCW Biologics Published a Pivotal Scientific Paper in Aging Cell Subcutaneous Administration of HCW9218 Systemically Reduces Senescent Cells and Alleviates Senescence-Associated Secretory Phenotype Factors in Mice MIRAMAR, Fla., April 03, 2023 (GLOBE NEWSWIRE) -- HCW Biologi...

2023-03-28 16:53:57 ET HCW Biologics press release ( NASDAQ: HCWB ): Q4 GAAP EPS of -$0.15 misses by $0.01 . Revenue of $1.3M. As of December 31, 2022, the Company held $22.3 million in cash and cash equivalents, For further details see: HCW Biologics GAA...

MIRAMAR, Fla., March 28, 2023 (GLOBE NEWSWIRE) -- HCW Biologics Inc. (the “Company” or “HCW Biologics”) (NASDAQ: HCWB), a clinical-stage biopharmaceutical company focused on discovering and developing novel immunotherapies to lengthen healthspan by disrupting the l...

Summary I explain why I've added Organigram to my tax loss selling basket. I also review the company's performance and risks. Finally, I recap my entire 2022 tax loss selling basket of stocks, some of which I didn't have time to write up individually. Tax Loss Selling Strategy...